Guy Young/LinkedIn;
Mark T. Reding/emedevents.com/
Mar 12, 2026, 11:50
Guy Young: Clinical Conversations on Gene Therapy Progress in Hemophilia B at THSNA 2026
Guy Young, Director of the Hemostasis and Thrombosis Center at Children’s Hospital Los Angeles, shared a post on LinkedIn:
“I’m looking forward to speaking at THSNA 2026 on Driving Innovation Forward in Hemophilia B With Gene Therapy: Clinical Conversations on Progress and Guidance on Practical Delivery.
Join Mark T. Reding, MD and I as we discuss:
- Clarifying the role of gene therapy in hemophilia B within an evolving treatment landscape
- Improving patient selection and counseling in real-world practice
- Operationalizing delivery – from referral coordination to infusion management, monitoring, and long-term follow-up across care settings
This symposium will take place live in person on March 21 at 6:45 AM PDT at the Oregon Convention Center in Portland during the THSNA 2026 Annual Meeting, with a live virtual program to follow on March 30 at 7:00 PM EDT.
Other posts featuring Guy Young on Hemostasis Today.
-
Mar 12, 2026, 11:44Yves Bikorimana: Causes, Diagnosis, and Management of Neonatal Alloimmune Thrombocytopenia
-
Mar 12, 2026, 11:33Kymentie Ferdinande: New Insights Into Platelet Function and Thrombus Formation in Cirrhosis
-
Mar 12, 2026, 11:17Tareq Abadl: Why Do Some People Bruise And Bleed So Easily?
-
Mar 12, 2026, 11:15Matthew Flick: The Interplay of the Fibrinogen αC-Region, Hypofibrinogenemia, and GPVI in Arterial Thrombosis
-
Mar 12, 2026, 11:08Stephen Twumasi: The Impact of Hepatitis B Infection on the Coagulation System During Pregnancy
-
Mar 12, 2026, 11:05Robert Lufkin: One Minute of Wisdom from Robert Lustig on Cholesterol, Sugar, and Heart Disease
-
Mar 12, 2026, 10:36Cynthia Dunbar: Retiring From NIH After 39 Years to Advance Advocacy and Research in Hematology
-
Mar 11, 2026, 23:05Ney Carter Borges: A Safety Advantage of Apixaban over Rivaroxaban Without Clear Superiority
-
Mar 11, 2026, 22:01The Results of Landmark COBRRA Trial in Acute VTE Management – ISTH